South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determining the best dose for a cancer drug combination in clinical trials.The co ...
The sweeping U.S. cuts to foreign aid are potentially killing thousands of people a day due to factors like starvation and ...
The Producto Group is pleased to announce the appointment of Alyson Trust as Chief Financial Officer (CFO), effective immediately. In her role, Mrs. Trust will be responsible for The Producto Group’s ...
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: ...
DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company”), the Dallas-based holding company of The Dallas Morning News and Medium Giant, today reported financial ...
News-Medical.Net on MSN1d
IL-12 targeting could open pathways for new Alzheimer's treatmentsResearchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback